STOCK TITAN

PACS Group (PACS) DEF 14A Filings

PACS NYSE

Here are the DEF 14A proxy statements from PACS Group, Inc. (PACS) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow PACS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PACS filings page.

Rhea-AI Summary

PACS Group, Inc. is asking stockholders to vote at its fully virtual 2026 Annual Meeting on June 10, 2026. Holders of 157,165,029 common shares as of April 15, 2026 can vote online.

Stockholders will elect two Class II directors (Evelyn Dilsaver and Mark Hancock) to terms ending in 2029, ratify Ernst & Young LLP as auditor for 2026, and cast an advisory vote on 2025 executive pay. PACS uses a classified board and is a controlled company, with Jason Murray and Mark Hancock together holding about 70% of the voting power.

Executive pay blends base salary, a quarterly Management Bonus Program funded at 8% of Adjusted EBITDA, and time-vested RSUs. In 2025, strong Adjusted EBITDA produced large bonuses, including about $7.3 million each for Murray and Hancock, plus additional retention and special bonuses for several executives.

Rhea-AI Summary

PACS Group, Inc. is asking stockholders to vote at its fully virtual 2025 Annual Meeting on December 19, 2025. Holders of common stock as of the November 10, 2025 record date, when 156,615,444 shares were outstanding, are entitled to one vote per share.

Stockholders will vote on electing two Class I directors (Taylor Leavitt and Jacqueline Millard) to terms ending at the 2028 meeting, ratifying Ernst & Young LLP as independent auditor for 2025, choosing how often to hold future say‑on‑pay votes (the Board recommends every one year), and approving on an advisory basis the 2024 compensation of named executive officers.

The Board highlights that PACS is a NYSE “controlled company,” with co‑founders Jason Murray and Mark Hancock collectively holding about 70% of voting power and possessing board designation rights. The proxy also describes board committee structures, independence determinations, risk oversight, and a shift in 2024 to more market‑standard executive pay practices, including an Adjusted EBITDA‑based bonus plan, new RSU grants with five‑year vesting, and a severance plan for executives.